209 related items for PubMed ID: 15363816
1. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension.
Labiós M, Martínez M, Gabriel F, Guiral V, Munoz A, Aznar J.
Am J Hypertens; 2004 Sep; 17(9):757-63. PubMed ID: 15363816
[Abstract] [Full Text] [Related]
2. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
Labiós M, Martínez M, Gabriel F, Guiral V, Aznar J.
Thromb Res; 2006 Sep; 118(4):447-53. PubMed ID: 16242179
[Abstract] [Full Text] [Related]
3. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Hanon O, Berrou JP, Negre-Pages L, Goch JH, Nádházi Z, Petrella R, Sedefdjian A, Sévenier F, Shlyakhto EV, Pathak A.
J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
[Abstract] [Full Text] [Related]
4. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA, Punzi CF.
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[Abstract] [Full Text] [Related]
5. The effect of treatment with eprosartan on pulse pressure: factors predicting response.
de la Sierra A, Muñoz A, Arcos E, López JS, Relats J, ETAPA-2 study investigators.
Can J Cardiol; 2004 Oct; 20 Suppl C():17C-22C. PubMed ID: 16807619
[Abstract] [Full Text] [Related]
6. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
Teitelbaum I, Chilvers M, Reiz RJ.
Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618
[Abstract] [Full Text] [Related]
7. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
Conter HS, McKay DW, Reiz RJ.
Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
[Abstract] [Full Text] [Related]
8. Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS.
Labiós M, Martínez M, Gabriel F, Guiral V, Ruiz-Aja S, Aznar J.
Thromb Res; 2006 Oct; 117(4):403-9. PubMed ID: 16461073
[Abstract] [Full Text] [Related]
9. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[Abstract] [Full Text] [Related]
10. Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
Pathak A, Hanon O, Negre-Pages L, Sevenier F, OSCAR investigators.
Fundam Clin Pharmacol; 2007 Apr; 21(2):199-205. PubMed ID: 17391293
[Abstract] [Full Text] [Related]
11. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
Robles NR, Martín-Agueda B, López-Muñoz F, Alamo C, Investigators of the ESTEPP Study.
Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
[Abstract] [Full Text] [Related]
12. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Sachse A, Verboom CN, Jäger B.
J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
[Abstract] [Full Text] [Related]
13. Superoxide dismutase and catalase anti-oxidant activity in leucocyte lysates from hypertensive patients: effects of eprosartan treatment.
Labiós M, Martínez M, Gabriel F, Guiral V, Dasi F, Beltrán B, Muñoz A.
J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):24-30. PubMed ID: 19286755
[Abstract] [Full Text] [Related]
14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[Abstract] [Full Text] [Related]
15. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB.
Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
[Abstract] [Full Text] [Related]
16. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S, Hammersen F, Kulschewski A, Frerichs A, Frieg R, Hahnheiser D, Reich G, Schnieders M, Schrandt G, Schrader J.
Dtsch Med Wochenschr; 2006 Nov 17; 131(46):2580-5. PubMed ID: 17096303
[Abstract] [Full Text] [Related]
17. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
Clin Ther; 2005 Jul 17; 27(7):1013-21. PubMed ID: 16154480
[Abstract] [Full Text] [Related]
18. Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
Shlyakhto E.
Curr Med Res Opin; 2007 Nov 17; 23 Suppl 5():S13-8. PubMed ID: 18093409
[Abstract] [Full Text] [Related]
19. Effectiveness of eprosartan in diabetic hypertensive patients.
Robles NR, Martín-Agueda B, López-Muñoz F, Alamo C, Investigators of ESTEPP Study.
Eur J Intern Med; 2008 Jan 17; 19(1):27-31. PubMed ID: 18206598
[Abstract] [Full Text] [Related]
20. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Breeze E, Rake EC, Donoghue MD, Fletcher AE.
J Hum Hypertens; 2001 Dec 17; 15(12):857-62. PubMed ID: 11773988
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
